VCEL (STOCKS)
Vericel Corporation
$38.290000
+0.830000 (+2.22%)
Prev close: $37.460000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Dominick C. Colangelo
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,955.40M
- Employees
- 357
- P/E (TTM)
- 91.59
- P/B (TTM)
- 5.36
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $292.09M |
| Benefits Costs and Expenses | $258.88M |
| Cost Of Revenue | $73.49M |
| Costs And Expenses | $269.98M |
| Gross Profit | $218.59M |
| Nonoperating Income/Loss | $6.55M |
| Operating Expenses | $202.82M |
| Selling, General, and Administrative Expenses | $174.41M |
| Research and Development | $28.41M |
| Operating Income/Loss | $15.77M |
| Income/Loss From Continuing Operations After Tax | $21.46M |
| Income/Loss From Continuing Operations Before Tax | -$30.59M |
| Net Income/Loss | $21.46M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $21.46M |
| Net Income/Loss Available To Common Stockholders, Basic | $21.46M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $0.43 |
| Diluted Earnings Per Share | $0.42 |
| Basic Average Shares | 151,714,000 |
| Diluted Average Shares | 154,944,000 |
| Assets | $485.63M |
| Current Assets | $244.06M |
| Inventory | $18.35M |
| Other Current Assets | $225.71M |
| Noncurrent Assets | $241.56M |
| Liabilities | $129.40M |
| Current Liabilities | $47.16M |
| Accounts Payable | $19.01M |
| Wages | $4.25M |
| Other Current Liabilities | $23.89M |
| Noncurrent Liabilities | $82.24M |
| Equity | $356.23M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $356.23M |
| Liabilities And Equity | $485.63M |
| Net Cash Flow From Operating Activities | $61.69M |
| Net Cash Flow From Operating Activities, Continuing | $61.69M |
| Net Cash Flow From Investing Activities | -$33.00M |
| Net Cash Flow From Investing Activities, Continuing | -$33.00M |
| Net Cash Flow From Financing Activities | $893.00K |
| Net Cash Flow From Financing Activities, Continuing | $893.00K |
| Net Cash Flow | $29.59M |
| Net Cash Flow, Continuing | $29.59M |
| Comprehensive Income/Loss | $21.11M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $21.16M |
| Other Comprehensive Income/Loss | $21.66M |